← Leaderboards
Alexander Y Nikitin
Cornell University Ithaca
$12,745,590
Attributed
$12,745,590
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $863.3K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,745,590 · 8
By mechanism
R01$11,981,775 · 6
K26$476,391 · 1
R56$287,424 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsCellsStem CellsEpitheliumCarcinogenesisMolecularNeoplasmsTp53 GenePredispositionBaseStemMouse ModelNatural RegenerationCessation Of LifeLeadPathogenesisCell LineageStromal CellsDistalSelf-RenewalTumorLocationTextTumor Suppressor Genes
Grant awards (42)
Endometrial epithelial stem cells and cancer$433,834
R01 · FY2025 · CA · contact PI
Cancer-prone cell states of the fallopian tubal epithelium$429,513
R01 · FY2025 · CA · contact PI
Endometrial epithelial stem cells and cancer$412,143
R01 · FY2024 · CA · contact PI
Cancer-prone cell states of the fallopian tubal epithelium$408,037
R01 · FY2024 · CA · contact PI
Endometrial epithelial stem cells and cancer$425,157
R01 · FY2023 · CA · contact PI
Cancer-prone cell states of the fallopian tubal epithelium$420,922
R01 · FY2023 · CA · contact PI
Endometrial epithelial stem cells and cancer$425,157
R01 · FY2022 · CA · contact PI
Cancer-prone cell states of the fallopian tubal epithelium$420,922
R01 · FY2022 · CA · contact PI
Endometrial epithelial stem cells and cancer$433,834
R01 · FY2021 · CA · contact PI
Cancer-prone cell states of the fallopian tubal epithelium$429,513
R01 · FY2021 · CA · contact PI
Neuroendocrine mechanisms of prostate cancer progression$49,997
R01 · FY2020 · CA · contact PI
Origins of Ovarian Carcinoma$348,015
R01 · FY2019 · CA · contact PI
Neuroendocrine mechanisms of prostate cancer progression$337,700
R01 · FY2019 · CA · contact PI
Origins of Ovarian Carcinoma$421,580
R01 · FY2018 · CA · contact PI
Neuroendocrine mechanisms of prostate cancer progression$348,145
R01 · FY2018 · CA · contact PI
Origins of Ovarian Carcinoma$358,780
R01 · FY2017 · CA · contact PI
Neuroendocrine mechanisms of prostate cancer progression$348,145
R01 · FY2017 · CA · contact PI
Origins of Ovarian Carcinoma$358,780
R01 · FY2016 · CA · contact PI
Neuroendocrine mechanisms of prostate cancer progression$348,145
R01 · FY2016 · CA · contact PI
Origins of Ovarian Carcinoma$358,780
R01 · FY2015 · CA · contact PI
Neuroendocrine mechanisms of prostate cancer progression$348,145
R01 · FY2015 · CA · contact PI
Determinants of Metastatic Progression$261,523
R01 · FY2012 · CA · contact PI
Determinants of Metastatic Progression$261,695
R01 · FY2011 · CA · contact PI
Determinants of Metastatic Progression$269,961
R01 · FY2010 · CA · contact PI
Determinants of Metastatic Progression$270,128
R01 · FY2009 · CA · contact PI
Modeling ovarian carcinoma by defined genetic alterations$266,292
R01 · FY2009 · CA · contact PI
Determinants of Metastatic Progression$270,291
R01 · FY2008 · CA · contact PI
Modeling ovarian carcinoma by defined genetic alterations$266,292
R01 · FY2008 · CA · contact PI
Determinants of Metastatic Progression$287,424
R56 · FY2007 · CA · contact PI
Modeling ovarian carcinoma by defined genetic alterations$266,292
R01 · FY2007 · CA · contact PI
Modeling ovarian carcinoma by defined genetic alterations$294,763
R01 · FY2006 · CA · contact PI
Modeling metastasis by controlled inactivation of Rb$276,369
R01 · FY2006 · CA · contact PI
ADVANCING MENTORING AND RESEARCH IN MOUSE PATHOBIOLOGY$100,357
K26 · FY2006 · RR · contact PI
Modeling metastasis by controlled inactivation of Rb$283,020
R01 · FY2005 · CA
Modeling ovarian carcinoma by defined genetic alterations$280,845
R01 · FY2005 · CA
ADVANCING MENTORING AND RESEARCH IN MOUSE PATHOBIOLOGY$100,434
K26 · FY2005 · RR
Modeling metastasis by controlled inactivation of Rb$283,020
R01 · FY2004 · CA
ADVANCING MENTORING AND RESEARCH IN MOUSE PATHOBIOLOGY$94,595
K26 · FY2004 · RR
Modeling metastasis by controlled inactivation of Rb$283,020
R01 · FY2003 · CA
ADVANCING MENTORING AND RESEARCH IN MOUSE PATHOBIOLOGY$91,840
K26 · FY2003 · RR
Modeling metastasis by controlled inactivation of Rb$283,020
R01 · FY2002 · CA
ADVANCING MENTORING AND RESEARCH IN MOUSE PATHOBIOLOGY$89,165
K26 · FY2002 · RR